Phase II evaluation of cis-dichlorodiammineplatinum(II) in lymphomas: A southwest oncology group study

Cancer Treatment Reports

Volumn 63, Issue 9-10, 1979, Pages 1605-1608

  Rossof, A H ^a   Coltman Jr , C A ^a   Jones, S E ^a   Talley, R W ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN;

ADVERSE DRUG REACTION; ANOREXIA; BLOOD AND HEMOPOIETIC SYSTEM; CANCER CHEMOTHERAPY; DIARRHEA; HODGKIN DISEASE; HYPERURICEMIA; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY; LEUKOPENIA; LYMPHOMA; MAJOR CLINICAL STUDY; NAUSEA; NEPHROTOXICITY; NONHODGKIN LYMPHOMA; RETICULOENDOTHELIAL SYSTEM; THERAPY; THROMBOCYTOPENIA; VOMITING;

BONE MARROW; CISPLATIN; DRUG EVALUATION; GASTROINTESTINAL SYSTEM; HODGKIN DISEASE; HUMAN; KIDNEY; LYMPHOMA; REMISSION, SPONTANEOUS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0018579143     PISSN: 03615960     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)